Amphix Bio
Amphix Bio is a preclinical-stage company developing Supramolecular Therapeutic Peptides (STPs).
- Headquarters
- Chicago, Illinois, United StatesSource: RevenueBaseRetrieved October 13, 2026
- Employee range
- 1 to 10Source: RevenueBaseRetrieved October 13, 2026
- Published list appearances
- 8 supported appearances ↗Source: RevenueBase lists
What does Amphix Bio do?
Its therapies trigger targeted signaling pathways and form scaffolds to support biological repair. The platform modifies immunological response and initiates regenerative processes to restore function lost from injury, disease, or aging.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
Company lists.
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Share your recognition
Embeddable award for your website
Sources & data notes.
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 13, 2026, September 14, 2026, September 15, 2026, September 18, 2026, September 29, 2026 and October 7, 2026. How the company lists are built.
Something changed?
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
One company is just the start.
Explore more companies by name, headquarters and business focus.